Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use

Overview of attention for article published in Diabetes Therapy, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 69 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 13,820 followers.

RT @AmarPut: @drpatrickholmes @AliJChakera @vinodpatel12345 @kamleshkhunti @LRWEUnit @DSNforumUK @youngdiab @ABCDiab @AbdTahrani @parthaska…

@drpatrickholmes @AliJChakera @vinodpatel12345 @kamleshkhunti @LRWEUnit @DSNforumUK @youngdiab @ABCDiab @AbdTahrani @parthaskar @LDC_tweets @DiabetesUK @athattersley https://t.co/h9L7kWULM7 ah yes- this was it

RT @ChristosArgyrop: @LTummalapalli This question has been looked into the UK. About 16% of all patients with diabetes would have fulfilled…

Andrew McGovern et al compare trial data and the real-world use of #SGLT2 inhibitors https://t.co/7wWuWnQwzA @UniSurreyBioSci #diabetes #T2D

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.